✦ LIBER ✦

A single-centre study of treatment outcomes and survival in 120 patients with peripheral T-cell non-Hodgkin's lymphoma

✍ Scribed by J. Pellatt; J. Sweetenham; R. Pickering; L. Brown; B. Wilkins

Publisher: Springer
Year: 2002
Tongue: English
Weight: 57 KB
Volume: 81
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-002-0450-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rituximab plus ASHAP for the treatment o

Rituximab plus ASHAP for the treatment of patients with relapsed or refractory aggressive non-Hodgkin’s lymphoma: a single-centre study of 20 patients

✍ Semra Aydin; Ulrich Dührsen; Holger Nückel 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 125 KB

A single-center study of treatment outco

A single-center study of treatment outcomes and survival in patients with primary gastric lymphomas between 1990 and 2003

✍ Barbara Jezeršek Novaković; Marjeta Vovk; Tanja Južnič Šetina 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 166 KB

Competitive polymerase chain reaction to

Competitive polymerase chain reaction to quantify tumor cells in peripheral blood of patients with T(14;18)-bearing follicular non-Hodgkin's lymphoma: An exploratory study in 8 patients

✍ Marc Debled; Isabelle Hostein; Thérèse Astier-Gin; Houchingue Eghbali; Françoise 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 115 KB 👁 3 views

Detection of residual disease in follicular lymphoma is hampered by the observation of t(14;18)-bearing cells in the blood of healthy adult humans. To overcome this problem, we decided to validate a quantification method of t(14;18)bearing cells and test it in t(14;18)-bearing follicular lymphomas (

Feasibility and toxicity of high-dose th

Feasibility and toxicity of high-dose therapy (HDT) supported by peripheral blood stem cells in elderly patients with multiple myeloma and non-Hodgkin's lymphoma: Survey from a single institution

✍ Massimo Magagnoli; Luca Castagna; Monica Balzarotti; Barbara Sarina; Inna Timofe 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 2 views

Treatment, patterns of failure, and surv

Treatment, patterns of failure, and survival of patients with Stage I nodal and extranodal non-Hodgkin's lymphomas, according to data in the population-based registry of the comprehensive cancer centre west

✍ Augustinus D. Krol; Jo Hermans; Lilian Dawson; Simone Snijder; Pierre W. Wijerma 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 2 views

## BACKGROUND. Primary extranodal lymphomas (EN-NHLs) are a heterogeneous category of tumors that are considered to be different from primary nodal non-Hodgkin's lymphomas (N-NHLs). To what extent these differences have clinical implications is currently not very clear, because knowledge of EN-NHL

A controversial issue: could a watch-and

A controversial issue: could a watch-and-wait policy for patients with non-Hodgkin's lymphoma clinical stage I or IE with no lymphoma left following diagnostic surgery be justified? Results of a single centre study

✍ Svetislav Jelić; Olivera Frim; Gordana Gligorijević; Dušica Gavrilović; Nebojša 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB 👁 2 views

Background: A subset of patients with non-Hodgkin's lymphoma (NHL) with clinical stage I or IE at presentation is left without other NHL localizations following surgery performed for diagnostic histology, and thus without any target lesion to judge the immediate effectiveness of immediately applied